Selective inhibition of eukaryotic translation initiation factor 2α dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic β-cell dysfunction and apoptosis

被引:266
作者
Cnop, Miriam
Ladriere, Laurence
Hekerman, Paul
Ortis, Fernanda
Cardozo, Alessandra K.
Dogusan, Zeynep
Flamez, Daisy
Boyce, Michael
Yuan, Junying
Eizirik, Decio L.
机构
[1] Free Univ Brussels, Erasmus Sch Med, Expt Med Lab, B-1070 Brussels, Belgium
[2] Erasme Univ Hosp, Div Endocrinol, B-1070 Brussels, Belgium
[3] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M607627200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Free fatty acids cause pancreatic beta-cell apoptosis and may contribute to beta-cell loss in type 2 diabetes via the induction of endoplasmic reticulum stress. Reductions in eukaryotic translation initiation factor (eIF) 2 alpha phosphorylation trigger P-cell failure and diabetes. Salubrinal selectively inhibits eIF2 alpha dephosphorylation, protects other cells against endoplasmic reticulum stress-mediated apoptosis, and has been proposed as a beta-cell protector. Unexpectedly, salubrinal induced apoptosis in primary beta-cells, and it potentiated the deleterious effects of oleate and palmitate. Salubrinal induced a marked eIF2 alpha phosphorylation and potentiated the inhibitory effects of free fatty acids on protein synthesis and insulin release. The synergistic activation of the PERK-eIF2 alpha branch of the endoplasmic reticulum stress response, but not of the IRE1 and activating transcription factor-6 pathways, led to a marked induction of activating transcription factor-4 and the pro-apoptotic transcription factor CHOP. Our findings demonstrate that excessive eIF2 alpha phosphorylation is poorly tolerated by beta-cells and exacerbates free fatty acid-induced apoptosis. This modifies the present paradigm regarding the beneficial role of eIF2 alpha phosphorylation in beta-cells and must be taken into consideration when designing therapies to protect beta-cells in type 2 diabetes.
引用
收藏
页码:3989 / 3997
页数:9
相关论文
共 58 条
[21]   Protection of Bcl-2 by salubrinal [J].
Kessel, David .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 346 (04) :1320-1323
[22]   BCL-6:: a possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells [J].
Kharroubi, I. ;
Lee, C. -H ;
Hekerman, P. ;
Darville, M. I. ;
Evans, R. M. ;
Eizirik, D. L. ;
Cnop, M. .
DIABETOLOGIA, 2006, 49 (10) :2350-2358
[23]   Free fatty acids and Cytokines induce pancreatic β-cell apoptosis by different mechanisms:: Role of nuclear factor-κB and endoplasmic reticulum stress [J].
Kharroubi, I ;
Ladrière, L ;
Cardozo, AK ;
Dogusan, Z ;
Cnop, M ;
Eizirik, DL .
ENDOCRINOLOGY, 2004, 145 (11) :5087-5096
[24]   Cloning, expression, and cellular localization of the oncogenic 58-kDa inhibitor of the RNA-activated human and mouse protein kinase [J].
Korth, MJ ;
Lyons, CN ;
Wambach, M ;
Katze, MG .
GENE, 1996, 170 (02) :181-188
[25]   Molecular regulation of monocyte chemoattractant protein-1 expression in pancreatic β-cells [J].
Kutlu, B ;
Darville, MI ;
Cardozo, AK ;
Eizirik, DL .
DIABETES, 2003, 52 (02) :348-355
[26]   Pancreatic β-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK [J].
Ladiges, WC ;
Knoblaugh, SE ;
Morton, JF ;
Korth, MJ ;
Sopher, BL ;
Baskin, CR ;
MacAuley, A ;
Goodman, AG ;
LeBoeuf, RC ;
Katze, MG .
DIABETES, 2005, 54 (04) :1074-1081
[27]   MULTIPLE EFFECTS OF LEUCINE ON GLUCAGON, INSULIN, AND SOMATOSTATIN SECRETION FROM THE PERFUSED RAT PANCREAS [J].
LECLERCQMEYER, V ;
MARCHAND, J ;
WOUSSENCOLLE, MC ;
GIROIX, MH ;
MALAISSE, WJ .
ENDOCRINOLOGY, 1985, 116 (03) :1168-1174
[28]   PURIFICATION AND PARTIAL CHARACTERIZATION OF A CELLULAR INHIBITOR OF THE INTERFERON-INDUCED PROTEIN-KINASE OF MR 68,000 FROM INFLUENZA VIRUS-INFECTED CELLS [J].
LEE, TG ;
TOMITA, J ;
HOVANESSIAN, AG ;
KATZE, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6208-6212
[29]  
LING Z, 1994, DIABETOLOGIA, V37, P15
[30]   Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2 [J].
Lu, PD ;
Jousse, C ;
Marciniak, SJ ;
Zhang, YH ;
Novoa, I ;
Scheuner, D ;
Kaufman, RJ ;
Ron, D ;
Harding, HP .
EMBO JOURNAL, 2004, 23 (01) :169-179